Asia Pacific Bangkok Beijing Hanoi Ho Chi Minh City Hong Kong Jakarta Kuala Lumpur Manila Melbourne Shanghai Singapore Sydney Taipei Tokyo Europe & Middle East Abu Dhabi Almaty Amsterdam Antwerp Bahrain Baku Barcelona Berlin Brussels Budapest Cairo Doha Dusseldorf Frankfurt/ Main Geneva Istanbul Kyiv London Luxembourg Madrid Milan Moscow Munich Paris Prague Riyadh Rome St. Petersburg Stockholm Vienna Warsaw Zurich North & South America Bogota Brasilia* Buenos Aires Caracas Chicago Dallas Guadalajara Houston Juarez Mexico City Miami Monterrey New York Palo Alto Porto Alegre* Rio de Janeiro* San Diego San Francisco Santiago Sao Paulo* Tijuana Toronto Valencia Washington, DC
| American Medical Systems Europe B.V. Vestastraat 6 6468 EX Kerkrade The Netherlands (the "Addressee") 23 February 2022 10002148-50811343/401861759-v7\EMEA_DMS/MOL/JOR1 Re: American Medical Systems Europe B.V. Dear Addressees, I. Introduction We are acting as special Dutch legal counsel (advocaten) to American Medical Systems Europe B.V., a private company with limited liability (besloten vennootschap met beperkte aansprakelijkheid) incorporated under the laws of The Netherlands, having its corporate seat (statutaire zetel) in Amsterdam, The Netherlands, its registered office at Vestastraat 6, 6468 EX Kerkrade, The Netherlands, and registered with the trade register of the Chamber of Commerce ("Chamber of Commerce", Kamer van Koophandel) under number 34185686 ("AMS Europe") in connection with a Registration Statement on Form S-3, dated 23 February 2022 (the "Registration Statement") filed under the Securities Act of 1933, as amended from time to time (the "Securities Act") by AMS Europe and Boston Scientific Corporation ("Boston Scientific", and together with the AMS Europe, the "Registrants") on 23 February 2022. The Registration Statement relates to, among other things, the issuance and sale from time to time, pursuant to Rule 415 under the Securities Act, of an unspecified amount of debt securities (the "Debt Securities") and guarantees of the Debt Securities (the "Guarantees" and, together with the Debt Securities, the "Securities") by either of the Registrants. |